NeoGenomics, Inc.NEONASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
43.28%
↑ 141% above average
Average (39q)
-105.91%
Historical baseline
Range
High:1242.61%
Low:-4675.44%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 43.28% |
| Q2 2025 | -71.17% |
| Q1 2025 | -51.21% |
| Q4 2024 | 13.19% |
| Q3 2024 | 3.39% |
| Q2 2024 | 28.22% |
| Q1 2024 | -64.57% |
| Q4 2023 | 23.23% |
| Q3 2023 | 19.06% |
| Q2 2023 | 14.77% |
| Q1 2023 | -32.94% |
| Q4 2022 | 33.22% |
| Q3 2022 | 0.48% |
| Q2 2022 | 23.69% |
| Q1 2022 | -25.17% |
| Q4 2021 | -4.67% |
| Q3 2021 | -77.55% |
| Q2 2021 | -48.06% |
| Q1 2021 | -372.74% |
| Q4 2020 | 18.63% |
| Q3 2020 | 124.69% |
| Q2 2020 | -257.21% |
| Q1 2020 | -328.05% |
| Q4 2019 | -36.57% |
| Q3 2019 | -18.29% |
| Q2 2019 | 75.75% |
| Q1 2019 | -9.68% |
| Q4 2018 | -28.04% |
| Q3 2018 | 393.70% |
| Q2 2018 | -68.30% |
| Q1 2018 | -44.17% |
| Q4 2017 | 294.75% |
| Q3 2017 | -275.34% |
| Q2 2017 | 1242.61% |
| Q1 2017 | 96.08% |
| Q4 2016 | -310.39% |
| Q3 2016 | -36.39% |
| Q2 2016 | 14.10% |
| Q1 2016 | 136.85% |
| Q4 2015 | -4675.44% |